H

Herantis Pharma
HRTIS

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€33.85M
EV
€31.79M
Shares Outstanding
24.09M
Beta
0.38

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€1.90
P/E 2024E
-
P/Revenue 2024E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Herantis Pharma Oyj

gainify

H

Herantis Pharma Oyj

HRTIS

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson’s disease (PD). Its lead product in pipeline includes HER-096, an advanced small synthetic chemical pepti...

Sector

Healthcare

Industry

Biotechnology

CEO

Vuolanto, Antti

Employees

11

IPO Date

2014-06-11

Headquarters

Bertel Jungin Aukio 1, Espoo, Uusimaa, 02600, Finland

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved